Managers / Q4 2020 · view latest →
Wesleyan Assurance Society
CIK 0001773368 · COLMORE CIRCUS QUEENSWAY, BIRMINGHAM, X0, B4 6AR · 0121 200 9133
Summary
Wesleyan Assurance Society reported $696M in U.S.-listed holdings across 94 positions for Q4 2020.
Its largest position, MSFT, represents 7.1% of the portfolio.
Compared with Q3 2020, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.4% · $692M
- Other · 0.4% · $3M
- Closed-End Fund · 0.3% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VTRSVIATRIS INC | NEW | +9.1K | 9.1K | +$170,000 | $170,000 |
| SBUXSTARBUCKS CORP | ADDED | +1.8K | 16.8K | +$509,000 | $2M |
| CVXCHEVRON CORP NEW | HELD | −4.1K | 115.8K | +$1M | $10M |
| DISDISNEY WALT CO | HELD | +1.0K | 106.6K | +$6M | $19M |
| CATCATERPILLAR INC DEL | HELD | −1.0K | 119.3K | +$4M | $22M |
| CCITIGROUP INC | HELD | +0 | 302.4K | +$6M | $19M |
| JPMJPMORGAN CHASE & CO | HELD | +0 | 153.2K | +$5M | $19M |
| AAPLAPPLE INC | HELD | +0 | 274.6K | +$5M | $36M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.7B | 106 | Apr 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.7B | 109 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.7B | 106 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.5B | 108 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.3B | 107 | May 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.3B | 108 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 104 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.2B | 105 | Jul 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.1B | 102 | Apr 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.0B | 103 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $900M | 103 | Nov 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $936M | 103 | Jul 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $863M | 101 | May 5, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $814M | 100 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $651M | 100 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $699M | 99 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $821M | 96 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $845M | 94 | Feb 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $783M | 94 | Oct 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $798M | 95 | Jul 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $753M | 94 | Apr 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $696M | 94 | Jan 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $608M | 93 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $569M | 93 | Jul 24, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $469M | 91 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $534M | 86 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $500M | 87 | Oct 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $507M | 87 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $482M | 84 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.